Research Briefing | May 25, 2021

Global | Coronavirus Watch: The limits of vaccines

Vaccines are the key to a safe and permanent transition to more normal conditions. But evidence from economies that already have implemented widespread vaccine rollouts confirms our long-held view that high vaccination rates will not be the sole factor.

Of the 20 economies that have delivered the swiftest rollouts, nine are small states with patchy data. Of the remaining 11, only five now have lower daily Covid cases than they did at the point they began vaccinations. On mortality rates, the equivalent figure is just six.

Lockdown stringency scores suggest an over-eagerness to lift restrictions has not necessarily been the reason for the worsening health situation in some of these economies. Also, the presence of several new variants in the UK, US, and Israel, which have recorded large falls in cases and deaths this year, suggests the spread of variants isn’t solely to blame.

Estimates that the first dose of the Sinopharm vaccine may be just 3% effective in preventing infection could explain why some economies have seen high vaccine take-up but surging cases. And new variants may have reduced the efficacy of some individual vaccines, also lowering immunity.

In all, the experiences of economies such as Israel provides grounds for optimism. But at the same time, developments in other economies show that a corner will not be turned simply by reaching a specific vaccine threshold.

 

Back to Resource Hub

Related Services

Office building in London

Post

High debt costs suggest European office price correction

Our analysis suggests a 10% correction is needed on average for the major office markets in Europe to compensate for the higher cost of debt, with prime yields required to soften by 10bps-75bps to generate a low-risk interest coverage ratio at a reasonable LTV.

Find Out More

Post

Why an ageing population doesn’t mean soaring inflation

What’s the future for inflation? Joachim Nagel, the new president of Germany's central bank, believes the rapidly ageing global population will play a key role – ramping up pressure on prices in the medium term. While we agree slowing labour supply will stifle output growth, in his recent discussion Nagel failed to fully consider the demand side of the argument.

Find Out More